Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Fosun Pharma acquired majority stake of Foshan Chanchen Hospital
CreateTime:2013-12-02 Editor:liaoyan
Text Size:       

Fosun Pharmaceutical (Group) Co. acquired 60% stake of Foshan City Chanchen Hospital with RMB 693 million. Based on the agreement, the Chanchen Hospital shall ensure that revenue from 2013-2015 reach RMB 90 million, 108 million and 129 million, respectively.

Fusun pharma maintains its core business pharmaceutical section's investment, in the meantime, also enhance its another strategic segment healthcare service competence. It is also a trend reflected by Gansu Duyiwei, Kangmei Pharma that traditional pharmaceutical companies are turning their attention on the real hospital operations.

Related Reports
China Blood Product Industry Report, 2020-2027
China Medical Robot Industry Report, 2020-2026
China In Vitro Diagnostic (IVD) Industry Report, 2019-2025
China Aged Care Industry Report, 2019-2025
China Dental Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1